Show simple item record

Some concerns from Turkey

dc.contributor.authorBilgin, Emre
dc.contributor.authorOzarli, İrem
dc.contributor.authorKılıc, Levent
dc.contributor.authorBolek, Ertuğrul Çagrı
dc.contributor.authorYardımcı, Gözde Kübra
dc.contributor.authorKaradağ, Ömer
dc.date.accessioned2021-03-16T13:16:37Z
dc.date.available2021-03-16T13:16:37Z
dc.date.issued2018-11-24
dc.identifier.citationBilgin E, Ozarli İ, Kılıç L, Bölek EÇ, Yardımcı GK, Karadağ Ö. Some concerns from Turkey. Ann Rheum Dis. 2020 Feb;79(2):e15. doi: 10.1136/annrheumdis-2018-214739. Epub 2018 Nov 24. PMID: 30472654.tr_TR
dc.identifier.urihttp://hdl.handle.net/11655/23565
dc.identifier.urihttp://dx.doi.org/10.1136/annrheumdis-2018-214739
dc.identifier.urihttps://pubmed.ncbi.nlm.nih.gov/30472654/
dc.description.abstractWe read the paper written by Kaneko et al with great interest.1 This study demonstrates the safety and efficacy of tocilizumab in patients with adult-onset Still’s disease (AOSD). This randomised placebo-controlled study could be one of the pioneer studies about the use of biological therapy in AOSD. We wanted to ask about some raising concernstr_TR
dc.language.isoentr_TR
dc.publisherBMJtr_TR
dc.relation.isversionof10.1136/annrheumdis-2018-214739
dc.rightsinfo:eu-repo/semantics/openAccesstr_TR
dc.rights.urihttp://creativecommons.org/publicdomain/zero/1.0/*
dc.subjectNSAIDstr_TR
dc.subjectAdult-onset Still’s diseasetr_TR
dc.subjectCorticosteroidstr_TR
dc.subject.lcshTıp uygulamasıtr_TR
dc.titleSome concerns from Turkeytr_TR
dc.typeinfo:eu-repo/semantics/articletr_TR
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.relation.journalAnn Rheum Distr_TR
dc.contributor.departmentİç Hastalıklarıtr_TR
dc.identifier.volume79tr_TR
dc.description.indexPubMedtr_TR
dc.fundingYoktr_TR


Files in this item

Name:
license_rdf
Size:
701bytes
Format:
application/rdf+xml
View/Open
Name:
e15.full.pdf
Size:
124.4Kb
Format:
PDF
View/Open

This item appears in the following Collection(s)

Show simple item record

info:eu-repo/semantics/openAccess
Except where otherwise noted, this item's license is described as info:eu-repo/semantics/openAccess